We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
(+11%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 5 |
Steel Dynamics
STLD
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$176M |
| 2 |
Coca-Cola
KO
|
+$151M |
| 3 |
Broadcom
AVGO
|
+$146M |
| 4 |
Microsoft
MSFT
|
+$140M |
| 5 |
ExxonMobil
XOM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Industrials | 11.65% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.56% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIE
1176
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $1.11M | 0.01% |
106,695
+1,500
| +1% | +$15.2K |
|
1177
Sprott Physical Gold and Silver Trust
CEF
$7.37B
| $1.11M | 0.01% |
62,163
| – | – |
|
1178
Curtiss-Wright
CW
$26.7B
| $1.11M | 0.01% |
+6,664
| New | +$1.11M |
|
|
KAHC
1179
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
| $1.11M | 0.01% |
+110,762
| New | +$1.11M |
|
1180
Chegg
CHGG
$118M
| $1.11M | 0.01% |
+43,860
| New | +$1.11M |
|
1181
State Street SPDR S&P Insurance ETF
KIE
$671M
| $1.11M | 0.01% |
+27,051
| New | +$1.09M |
|
1182
Kimbell Royalty Partners
KRP
$1.43B
| $1.11M | 0.01% |
66,302
+30,452
| +85% | +$535K |
|
1183
OceanFirst Financial
OCFC
$1.73B
| $1.11M | 0.01% |
52,045
+26,816
| +106% | +$585K |
|
1184
Legend Biotech
LEGN
$3.65B
| $1.11M | 0.01% |
22,154
-85,137
| -79% | -$4.12M |
|
1185
uniQure
QURE
$2.51B
| $1.1M | 0.01% |
+48,678
| New | +$1.05M |
|
1186
Agios Pharmaceuticals
AGIO
$2.15B
| $1.1M | 0.01% |
+39,061
| New | +$1.1M |
|
1187
SFL Corp
SFL
$1.6B
| $1.09M | 0.01% |
118,210
-176,904
| -60% | -$1.72M |
|
1188
MakeMyTrip
MMYT
$5.08B
| $1.09M | 0.01% |
+39,517
| New | +$1.14M |
|
1189
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.43B
| $1.09M | 0.01% |
24,841
-31,133
| -56% | -$1.34M |
|
1190
Enanta Pharmaceuticals
ENTA
$364M
| $1.09M | 0.01% |
23,396
-11,303
| -33% | -$515K |
|
|
CVSA
1191
Covista Inc
CVSA
$4.24B
| $1.09M | 0.01% |
+30,583
| New | +$1.19M |
|
1192
Mercer International
MERC
$45.3M
| $1.09M | 0.01% |
93,233
-54,669
| -37% | -$727K |
|
1193
Victory Capital Holdings
VCTR
$6.27B
| $1.08M | 0.01% |
+40,385
| New | +$1.14M |
|
1194
Schwab International Equity ETF
SCHF
$65.7B
| $1.08M | 0.01% |
+67,234
| New | +$1.05M |
|
|
SFBS
1195
ServisFirst Bancshares
SFBS
$4.92B
| $1.08M | 0.01% |
15,700
+2,057
| +15% | +$154K |
|
|
ROIC
1196
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.08M | 0.01% |
71,834
-97,011
| -57% | -$1.42M |
|
1197
TTM Technologies
TTMI
$11.2B
| $1.08M | 0.01% |
71,452
-56,705
| -44% | -$841K |
|
1198
ProPetro Holding
PUMP
$1.24B
| $1.08M | 0.01% |
+103,862
| New | +$1.09M |
|
1199
Iron Mountain
IRM
$37.3B
| $1.07M | 0.01% |
+21,547
| New | +$1.09M |
|
1200
Safety Insurance
SAFT
$1.51B
| $1.07M | 0.01% |
12,747
-12,745
| -50% | -$1.08M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review
As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
- Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
- Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
- Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.